When I read about a Tennessee school district considering alternative placements for kindergarten students with significant ...

All anyone in obesity care seems to be talking about these days is GLP-1s, which is drawing plenty of attention among benefit brokers and advisers who are talking with their employer clients about ...

The pandemic’s impact on our children’s development continues to reveal itself in classrooms across America. As districts and schools nationwide struggle to find qualified therapists, particularly ...

The healthcare industry succeeded in making behavioral healthcare more accessible, argues Machinify's Lisa Pincher. Now, it must build the infrastructure to support that care responsibly. What happens ...

GLP-1 medications (e.g., semaglutide and tirzepatide), originally developed for type 2 diabetes, are now transforming obesity care. These drugs are now delivering benefits such as significant weight ...